• BioRestorative Therapies appointed David Jenkins to its four-member board on November 10, 2026, filling the vacancy left by Jatinder Dhaliwal.
• Jenkins will chair the compensation and nominating and corporate governance committees, while also joining the audit committee.
• He has been an Akanda director since February 2023; he served as Kiaro Holdings' interim CEO and interim CFO from 2023–2025.
• Esha Randhawa resigned from the board and its committees effective November 5, 2026; Jatinder Dhaliwal departed those roles effective November 6, 2026.
• Donald J. Currie, a director since October 2026, also joined the audit committee.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioRestorative Therapies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-119019), on November 12, 2026, and is solely responsible for the information contained therein.